Form Type: 4

Accession Number:	0001104659-21-029884
Date:	2021-02-26
Issuer:	INTELLIA THERAPEUTICS, INC. (NTLA)
Original Submission Date:

Reporting Person:

FORMELA JEAN FRANCOIS
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET, SUITE 130 CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of Security	Transaction Date	2a. Deemed Execution Date	Transaction Code	Shares	Acquired or Disposed	Price per share	5. Amount of Securities Beneficially Owned Following Reported Transaction	6. Ownership Form Direct or Indirect	Nature of Indirect Ownership
COMMON STOCK	2021-02-26		S	501,945	d	$60.29	1,113,376	indirect	f3

Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security	Conversion or Exercise Price of Derivative Security	Transaction Date	Deemed Execution Date	Transaction Code	Number of Derivative Securities Acquired (A) or Disposed of (D)	Date Exercisable	Expiration Date	Title and Amount of Securities Underlying Derivative Security	Price of Derivative Security	Number of derivative Securities Beneficially Owned Following Reported Transaction(s)	Ownership Form: Direct (D) or Indirect (I)	Nature of Indirect Beneficial Ownership

Footnotes
ID	footnote
f1	represents shares sold by atlas venture fund ix, l.p. ("atlas ix"). atlas venture associates ix, l.p. ("ava ix lp"), is the general partner of atlas ix. atlas venture associates ix, llc ("ava ix llc") is the general partner of ava ix lp. dr. formela is a member of ava ix llc and disclaims section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
f2	the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $60.00219 - $60.50021, inclusive. the reporting person undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this form 4.
f3	represents shares held directly by atlas ix. the general partner of atlas ix is ava ix lp. ava ix llc is the general partner of ava ix lp. dr. formela is a member of ava ix llc and disclaims section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.

Elevate your investments